Glucagon-like peptide-1 (GLP-1) receptor agonists in type 2 diabetes and long-term complications: FOCUS on retinopathy.

Marchand, L ;
Luyton, C ;
Bernard, A

Department of Endocrinology and Diabetes, Centre Hospitalier Saint Joseph Saint Luc, Lyon. Department of Ophthalmology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite. Department of Ophthalmology, Centre Hospitalier Saint Joseph Saint Luc, Lyon, France.

Diabetic medicine : a journal of the British Diabetic Association. 2021;(1):e14390

Full text from:

Subscription
- Ovid Technologies, Inc.
- Wiley

Glucagon-like peptide-1 (GLP-1) receptor agonists in type 2 diabetes and long-term complications: FOCUS on retinopathy.

Other resources